Through the investigation of the GSE33814 dataset, we discovered that CDKN1B and NDUFA4 expressions were reduced in NAFLD, whereas TFAM expression was elevated (Figures 7D–F). This evidence concerns the gene CDKN1B and metabolic dysfunction-associated steatotic liver disease.